BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19864832)

  • 41. Transjugular intrahepatic portosystemic shunts: an update.
    Rosado B; Kamath PS
    Liver Transpl; 2003 Mar; 9(3):207-17. PubMed ID: 12619016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hematologic consequences of transjugular intrahepatic portosystemic shunts.
    Sanyal AJ; Freedman AM; Purdum PP; Shiffman ML; Luketic VA
    Hepatology; 1996 Jan; 23(1):32-9. PubMed ID: 8550045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incarceration of umbilical hernia following transjugular intrahepatic portosystemic shunt for the treatment of ascites.
    Trotter JF; Suhocki PV
    Liver Transpl Surg; 1999 May; 5(3):209-10. PubMed ID: 10226112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current ascites therapy].
    Ochs A
    Praxis (Bern 1994); 1997 Jan; 86(4):94-7. PubMed ID: 9064726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Management of ascitis in patients with cirrhosis].
    Arfaoui D; Ajmi S
    Tunis Med; 2007 Feb; 85(2):91-5. PubMed ID: 17665651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ascites after orthotopic liver transplantation in children.
    Herzog D; Martin S; Lallier M; Alvarez F
    Pediatr Transplant; 2005 Feb; 9(1):74-9. PubMed ID: 15667616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension.
    Gurubacharya DL; Mathura KC; Karki DB
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):327-33. PubMed ID: 16449830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M; Cholongitas E; Tibballs J; Burroughs A; Patch D
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
    Quiroga J; Sangro B; Núñez M; Bilbao I; Longo J; García-Villarreal L; Zozaya JM; Betés M; Herrero JI; Prieto J
    Hepatology; 1995 Apr; 21(4):986-94. PubMed ID: 7705810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiologically Placed Peritoneovenous Shunt is an Acceptable Treatment Alternative for Refractory Ascites Due to End-Stage Liver Disease.
    Bakhtiar M; Forde KA; Nadolski GJ; Soulen MC; Weinberg EM
    J Vasc Interv Radiol; 2021 Nov; 32(11):1606-1614. PubMed ID: 34416366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.
    Pose E; Cardenas A
    Dig Dis; 2017; 35(4):402-410. PubMed ID: 28468013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of ascitic fluid viscosity in differentiating the nature of ascites and in the prediction of renal impairment and duration of ICU stay.
    Hanafy AS
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1021-7. PubMed ID: 27218209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Ascites].
    Jeong SW
    Korean J Gastroenterol; 2018 Aug; 72(2):49-55. PubMed ID: 30145856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical usage of serum albumin to ascitic fluid albumin gradient and ascitic fluid total protein in pediatric ascites.
    Karnsakul W; Wasuwanich P; Ingviya T; Laengvejkal P; Vasilescu A; Imteyaz H; Scheimann AO
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101549. PubMed ID: 33268292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Ascites.
    Choudhury J; Sanyal AJ
    Curr Treat Options Gastroenterol; 2003 Dec; 6(6):481-491. PubMed ID: 14585237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ascites.
    Garcia N; Sanyal AJ
    Curr Treat Options Gastroenterol; 2001 Dec; 4(6):527-537. PubMed ID: 11696279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Management of refractory ascites by the automated low flow pump system (Alfapump)].
    Restellini S; Soares PC; Giostra E; Spahr L
    Rev Med Suisse; 2014 Sep; 10(440):1607-8, 1610-1. PubMed ID: 25276999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites.
    Stirnimann G; Banz V; Storni F; De Gottardi A
    Therap Adv Gastroenterol; 2017 Feb; 10(2):283-292. PubMed ID: 28203285
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.